The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Veteran immunologist and former Pfizer R&D leader joins Circurna to advance its circular RNA therapeutic platform ...

Codexis Inc. and Axolabs have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis ...

Researchers from Radboud university medical center and University of Basel have discovered new genetic causes of inherited ...

If there’s one thing orthopedic surgeons appreciate, it’s strong bones, solid structure — and a well-funded fellowship.

Plant viruses pose a serious and ongoing threat to global agriculture in tropical to temperate regions. Among the most damaging are begomoviruses, a group of DNA viruses spread by whiteflies that ...

Honeybees are vital to global food security, yet colony collapse threatens ecosystems and agriculture worldwide.   Discover ...

Although the year brought a steady stream of new treatments, tests, and cutting-edge science, experts worry about how politics will impact innovation long term.

Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.

Product Performance – potency and dosing: Cryogenic transmission electron microscopy (Cryo-TEM) revealed more uniform, solid-core particles. Increased lipid and RNA concentrations can enhance in vivo ...

Retinitis pigmentosa (RP) is a genetic eye disorder affecting around one in 5,000 people worldwide. It typically begins with ...